Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in children with Ph+ CML
NCT01221376Phase 2Unknown
- Start
- Feb 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in Chronic Myeloid Leukemia (CML). Status: unknown.
02
Drugs
03
Conditions
Chronic Myeloid Leukemia (CML)
Beyond the preview
Go deeper on NCT01221376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221376.